Overview

Electrical Brain Stimulation and Pharmacological Treatments in Autism Spectrum Disorder

Status:
Active, not recruiting
Trial end date:
2022-08-03
Target enrollment:
Participant gender:
Summary
This project aims to comparing the effectiveness of transcranial direct current stimulation with common pharmacological treatments on behavioral problems and cognitive deficits of children with autism spectrum disorder
Phase:
Phase 1
Details
Lead Sponsor:
The National Brain Mapping Laboratory (NBML)
Collaborators:
Ardabil University of Medical Sciences
Leibniz Research Centre for Working Environment and Human Factors
University of Tehran
Treatments:
Risperidone